Baxter said its stockholders approved the Amended and Restated 2021 Incentive Plan at the annual meeting on May 7, 2024. The plan allows the Compensation and Human Capital Committee to grant equity-based compensation, including stock options, restricted stock and restricted stock units.

1. 01

   Baxter said its stockholders approved the Amended and Restated 2021 Incentive Plan at the annual meeting on May 7, 2024. The plan allows the Compensation and Human Capital Committee to grant equity-based compensation, including stock options, restricted stock and restricted stock units.

2. 02

   The company said it filed the Amended and Restated Certificate of Incorporation, which stockholders approved, with the Secretary of State of Delaware on May 7, 2024, and that it became effective upon filing. The amendment permits exculpation of certain officers to the extent allowed under Delaware law.

3. 03

   Baxter said that at its annual meeting on May 7, 2024, 11 director nominees were elected. For José (Joe) E. Almeida, there were 403,353,452 votes for, 29,381,654 against and 1,388,922 abstentions.

4. 04

   The company said that in the 2023 advisory vote on executive compensation, there were 375,646,141 votes for and 57,650,282 against. A stockholder proposal on executives retaining significant stock was not approved, with 125,308,816 votes for and 307,423,574 against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.